Header

Pediatric Lymphoma Clinical Trials

Category:Pediatric
Status:Active

Displaying all 4 trials

Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma

This randomized phase III trial compares how well combination chemotherapy works when given with or without bortezomib in treating patients with newly diagnosed T-cell acute lymphoblastic leukemia ...

Diagnosis: Pediatric Lymphoma, Pediatric Leukemia

Phase: 3

Protocol Number: 15-032

Phase I Study of LDK378 in Pediatric, Malignancies With a Genetic Alteration in Anaplastic Lymphoma Kinase (ALK)

The purpose of this study is to estimate the maximum tolerated dose and/or recommended dose for expansion of LDK378 as a single agent, assess safety, tolerability and anti-tumor activity and charac...

Diagnosis: Pediatric Lymphoma

Phase: 1

Protocol Number: 13-180

Trial of CUDC-907 in Children and Young Adults With Relapsed or Refractory Solid Tumors, CNS Tumors, or Lymphoma

This research study is evaluating a novel drug called CUDC-907 as a possible treatment for resistant (refractory) pediatric solid tumors (including neuroblastoma), lymphoma, or brain tumors.

Diagnosis: Pediatric Solid Tumors, Pediatric Lymphoma

Phase: 1

Protocol Number: 16-371

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

This clinical trial studies the effects of dexrazoxane hydrochloride on biomarkers associated with cardiomyopathy and heart failure after cancer treatment. Studying samples of blood in the laborato...

Diagnosis: Pediatric Lymphoma, Pediatric Leukemia

Phase:

Protocol Number: 16-725

'